fig1
![Opportunities and challenges of implementing Pharmacogenomics in cancer drug development](https://image.oaes.cc/6d2b65b9-ce0f-4014-b759-80bfac536f07/2992.fig.1.jpg)
Figure 1. Distribution by field of FDA-approved drugs including pharmacogenomic information
Figure 1. Distribution by field of FDA-approved drugs including pharmacogenomic information
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/